A new treatment has been shown to effectively combat cognitive decline in mice with Alzheimer's disease. Alzheimer's disease, a progressive neurodegenerative disorder, stands as the primary cause of dementia. This condition leads to cognitive deterioration, memory loss, and eventually renders indiv
With something like this, how would one go about trying to sign up for more trails or early adoption blah blah?
Where trials will be run and eligibility will depend on industry/clinical partners. Unsure what the in/exclusion criteria will be as it seems to be better for early stages and alzheimers isn’t the easiest disease to catch early. They may also want to do an NHP (non-human primate) trial before going to humans depending on what side-effects they saw in the mice and weren’t mentioned in this news article.